Susan Couch

Gerson Lehrman Group, Inc. provides membership network for learning and expertise. The firm promotes knowledge exchange through conversations, small group convenings, mentorships, surveys, and other interactions with its network of experts. The company was founded by Alexander Saint-Amand, Thomas D. Lehrman, and Mark Gerson in 1998 and is headquartered in New York, NY.

McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY.

Abingworth Management, Inc. invests in life sciences and biomedical companies. The firm's investment in enables technologies, devices and instrumentation as well as companies developing products in therapeutic areas. The company was founded in 1973 and is headquartered in Menlo Park, CA.

TriNetX, Inc. provides an online data network for collaborative research. It enables hospitals, academic medical centers, physician networks, practices, and pharmaceuticals to participate in collaborative research and a public and private sustainability model for research informatics. The company was founded by Bard Geesaman in 2013 and is headquartered in Cambridge, MA.

Launch Therapeutics, Inc. provides investment and therapies development services. The CEO of the American company is Anshul Thakral.

Part of Saama Technologies, Inc., Saama Technologies LLC is a leading AI clinical analytics platform American company that enables the life sciences industry to conduct faster and safer clinical development and regulatory programs. The company is based in Campbell. The company's award-winning Life Science Analytics Cloud (LSAC) platform is used by over 50 biotech companies, including many of the top 20 pharmaceutical companies, to accelerate more than 1,500 studies, including the clinical trial that led to the world's first COVID-19 vaccine. LSAC's rich applications facilitate unprecedented and authoritative oversight and automation of comprehensive clinical research data, enabling companies to file new drug applications (NDAs) more efficiently and bring treatments to patients sooner.